Search

Your search keyword '"Carsetti, R."' showing total 372 results

Search Constraints

Start Over You searched for: Author "Carsetti, R." Remove constraint Author: "Carsetti, R."
372 results on '"Carsetti, R."'

Search Results

102. A Prospective Study on Children with Initial Diagnosis of Transient Hypogammaglobulinemia of Infancy: Results from the Italian Primary Immunodeficiency Network.

103. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells.

104. A novel mouse thymocyte antigen (F3Ag): down-regulation during the CD4+CD8+ double-positive stage indicates positive selection.

108. Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study

109. The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

110. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

111. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells

112. Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency

113. Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities

114. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

115. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies

116. Early-life gut microbiota under physiological and pathological conditions : the central role of combined meta-omics-based approaches

117. 17-beta-estradiol elicits genomic and non-genomic responses in mouse male germ cells

118. A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: Results from the Italian Primary Immunodeficiency Network

119. Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease.

120. Antibodies in breast milk: Pro-bodies designed for healthy newborn development.

121. B Cells Isolated from Individuals Who Do Not Respond to the HBV Vaccine Are Characterized by Higher DNA Methylation-Estimated Aging Compared to Responders.

122. TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells.

123. Editorial: IgA and mucosal immunity in vaccinology and in protection from infection.

124. SARS-CoV-2-specific mucosal immune response in vaccinated versus infected children.

125. Hyperactivation and altered selection of B cells in patients with paediatric Sjogren's syndrome.

126. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells.

127. Immunological characterization of an Italian PANDAS cohort.

128. SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

129. Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation.

130. Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome.

131. Persistently active interferon-γ pathway and expansion of T-bet + B cells in a subset of patients with childhood-onset systemic lupus erythematosus.

132. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.

133. Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients.

134. Defective peripheral B cell selection in common variable immune deficiency patients with autoimmune manifestations.

135. Natural killer cells and innate lymphoid cells 1 tune anxiety-like behavior and memory in mice via interferon-γ and acetylcholine.

136. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.

137. Influence of Defatting and Pasteurization on Nutrients and Oxidative Stress Markers in Human Milk.

138. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21 low B cells in hepatitis C virus-cured mixed cryoglobulinemia.

139. COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS.

140. The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age.

141. Asplenia and spleen hypofunction.

142. The immune response as a double-edged sword: The lesson learnt during the COVID-19 pandemic.

143. Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.

144. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose.

145. COVID-19-Associated Multisystem Inflammatory Syndrome in a Neonate with Atypical Coronary Artery Involvement.

146. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.

147. Hydroxytyrosol Recovers SARS-CoV-2-PLpro-Dependent Impairment of Interferon Related Genes in Polarized Human Airway, Intestinal and Liver Epithelial Cells.

148. T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies.

149. CD21 - CD27 - Atypical B Cells in a Pediatric Cohort Study: An Extensive Single Center Flow Cytometric Analysis.

150. Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy.

Catalog

Books, media, physical & digital resources